Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02661529 · ClinicalTrials.gov registry record · NA
Enhancement of Contrast Opacification for Echocardiographic Imaging of the Right Heart and Shunts
A NA study of Bidirectional Cardiovascular Shunt, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT02661529: Completed NA study of Bidirectional Cardiovascular Shunt, sponsored by Mayo Clinic.
NCT02661529 is a NA study of Bidirectional Cardiovascular Shunt that has completed, run by Mayo Clinic. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02661529, a NA study of Bidirectional Cardiovascular Shunt, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The study aims to answer whether the use of a mixture of blood and saline alone (limited air) provides the same degree of right-heart contrast enhancement as compared to the standard agitated saline (with air), during two types of echocardiograms.
Primary Outcome
The degree of right atrial opacification during echocardiogram will be rated with an image score; 0: poor/no opacification, 1: average opacification, 2: good opacification
Conditions Studied
Interventions
- PROCEDURE Transesophageal Echocardiogram (TEE)
- PROCEDURE Transthoracic Echocardiogram (TTE)
- OTHER Saline/Air Mixture
- OTHER Saline/Blood Mixture
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2016-01 |
| Est. Completion | 2016-07 |
| Phase | NA |
What the finished NCT02661529 record still lists
NCT02661529 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Bidirectional Cardiovascular Shunt appearing as the primary indexed condition, and to 4 interventions - of which Transesophageal Echocardiogram (TEE) is the first listed.
NCT02661529 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT02661529 about?
NCT02661529 is a clinical study titled "Enhancement of Contrast Opacification for Echocardiographic Imaging of the Right Heart and Shunts". The study aims to answer whether the use of a mixture of blood and saline alone (limited air) provides the same degree of right-heart contrast enhancement as compared to the standard agitated saline (with air), during two types of echocardiograms.
What is the current status of trial NCT02661529?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2016-01. Estimated completion is 2016-07.
What conditions does trial NCT02661529 study?
This clinical trial studies the following conditions: Bidirectional Cardiovascular Shunt.
What interventions are being tested in trial NCT02661529?
The interventions under investigation include: Transesophageal Echocardiogram (TEE) (PROCEDURE), Transthoracic Echocardiogram (TTE) (PROCEDURE), Saline/Air Mixture (OTHER), Saline/Blood Mixture (OTHER).
Who is sponsoring clinical trial NCT02661529?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02661529 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02661529's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia